[HTML][HTML] Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies

N Mehyar - Journal of Virus Eradication, 2023 - Elsevier
Introduction The recent outbreak of SARS-CoV-2 has significantly increased the need to find
inhibitors that target the essential enzymes for viral replication in host cells. This systematic …

Looking for SARS-CoV-2 therapeutics through computational approaches

M Vincenzi, FA Mercurio, M Leone - Current Medicinal Chemistry, 2023 - benthamdirect.com
Background: In the last few years, in silico tools, including drug repurposing coupled with
structure-based virtual screening, have been extensively employed to look for anti-COVID …

Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study

V Srivastava, B Naik, P Godara, D Das… - Molecular Diversity, 2024 - Springer
According to the Center for Disease Control and Prevention, as of August 23, 94 countries
had confirmed 42,954 Monkeypox Virus cases. As specific monkeypox drugs are not yet …

High-throughput virtual screening of small-molecule inhibitors targeting immune cell checkpoints to discover new immunotherapeutics for human diseases

S Singh, K Kumar, M Panda, A Srivastava, A Mishra… - Molecular Diversity, 2023 - Springer
Immunotherapy is widely used to treat various cancers, and the drugs used are called
immune checkpoint (ICP) inhibitors. Overexpression of immune cell checkpoints is reported …

Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach

S Singh, HN Banavath, P Godara, B Naik, V Srivastava… - 3 Biotech, 2022 - Springer
Omicron, a variant of concern (VOC) of SARS-CoV-2, emerged in South Africa in November
2021. Omicron has been continuously acquiring a series of new mutations, especially in the …

[HTML][HTML] Exploring malaria parasite surface proteins to devise highly immunogenic multi-epitope subunit vaccine for Plasmodium falciparum

P Bhalerao, S Singh, VK Prajapati, TK Bhatt - Journal of Genetic …, 2024 - Elsevier
Background Malaria has remained a major health concern for decades among people living
in tropical and sub-tropical countries. Plasmodium falciparum is one of the critical species …

Rational designing of peptide-ligand conjugates-based immunotherapy for the treatment of complicated malaria

P Godara, B Naik, R Meghwal, R Ojha, V Srivastava… - Life Sciences, 2022 - Elsevier
Aims Malaria deaths occur primarily due to complicated malaria associated with the
sequestration of Plasmodium falciparum-infected erythrocyte (PfIE) in the capillary …

Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics

M Pritam, S Dutta, KM Medicherla… - Journal of …, 2024 - Taylor & Francis
In the last few years, the worldwide population has suffered from the SARS-CoV-2
pandemic. The WHO dashboard indicated that around 504,079,039 people were infected …

Structure-based virtual screening approach reveals natural multi-target compounds for the development of antimalarial drugs to combat drug resistance

B Naik, N Gupta, P Godara, V Srivastava… - Journal of …, 2024 - Taylor & Francis
Compared to the previous year, there has been an increase of nearly 2 million malaria
cases in 2021. The emergence of drug-resistant strains of Plasmodium falciparum, the most …

Multifaceted mutational immunotherapeutic approach to design therapeutic mAbs to combat monkeypox disease via integrated screening algorithms and antibody …

S Singh, A Rao, A Mishra, A Mishra… - … Systems Design & …, 2023 - pubs.rsc.org
After a multi-country outbreak, the monkeypox (MPX) disease was designated a global
public health emergency on July 23, 2022. Some antiviral medications tailored to the …